NO914071L - Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive forbindelserInfo
- Publication number
- NO914071L NO914071L NO91914071A NO914071A NO914071L NO 914071 L NO914071 L NO 914071L NO 91914071 A NO91914071 A NO 91914071A NO 914071 A NO914071 A NO 914071A NO 914071 L NO914071 L NO 914071L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- procedure
- therapeutic active
- relations
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9012872A FR2668149B1 (fr) | 1990-10-18 | 1990-10-18 | Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO914071D0 NO914071D0 (no) | 1991-10-17 |
| NO914071L true NO914071L (no) | 1992-04-21 |
Family
ID=9401336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91914071A NO914071L (no) | 1990-10-18 | 1991-10-17 | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5212181A (fi) |
| EP (1) | EP0481853A1 (fi) |
| JP (1) | JPH04257579A (fi) |
| KR (1) | KR920008029A (fi) |
| AU (1) | AU638173B2 (fi) |
| CA (1) | CA2052760A1 (fi) |
| CS (1) | CS315291A3 (fi) |
| FI (1) | FI914906L (fi) |
| FR (1) | FR2668149B1 (fi) |
| HU (1) | HUT59391A (fi) |
| IE (1) | IE913653A1 (fi) |
| IL (1) | IL99779A0 (fi) |
| MX (1) | MX9101604A (fi) |
| NO (1) | NO914071L (fi) |
| NZ (1) | NZ240261A (fi) |
| PL (1) | PL292089A1 (fi) |
| PT (1) | PT99247A (fi) |
| ZA (1) | ZA918293B (fi) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0524846A1 (fr) * | 1991-06-27 | 1993-01-27 | Synthelabo | Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique |
| US6255322B1 (en) * | 1992-06-19 | 2001-07-03 | Pfizer Inc. | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| JP2686887B2 (ja) * | 1992-08-11 | 1997-12-08 | キッセイ薬品工業株式会社 | ピペリジノ−3,4−ジヒドロカルボスチリル誘導体 |
| FR2699534B1 (fr) * | 1992-12-21 | 1995-02-03 | Synthelabo | Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique. |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| AU7474998A (en) * | 1997-05-07 | 1998-11-27 | Emory University | Haloisoquinoline carboxamide |
| WO2004011430A1 (ja) * | 2002-07-25 | 2004-02-05 | Yamanouchi Pharmaceutical Co., Ltd. | ナトリウムチャネル阻害剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
-
1990
- 1990-10-18 FR FR9012872A patent/FR2668149B1/fr not_active Expired - Fee Related
-
1991
- 1991-10-11 EP EP91402716A patent/EP0481853A1/fr not_active Withdrawn
- 1991-10-15 MX MX9101604A patent/MX9101604A/es unknown
- 1991-10-16 HU HU913267A patent/HUT59391A/hu unknown
- 1991-10-16 PT PT99247A patent/PT99247A/pt not_active Application Discontinuation
- 1991-10-16 US US07/777,176 patent/US5212181A/en not_active Expired - Fee Related
- 1991-10-17 IE IE365391A patent/IE913653A1/en not_active Application Discontinuation
- 1991-10-17 NO NO91914071A patent/NO914071L/no unknown
- 1991-10-17 JP JP3269286A patent/JPH04257579A/ja active Pending
- 1991-10-17 CA CA002052760A patent/CA2052760A1/en not_active Abandoned
- 1991-10-17 ZA ZA918293A patent/ZA918293B/xx unknown
- 1991-10-17 IL IL99779A patent/IL99779A0/xx unknown
- 1991-10-17 FI FI914906A patent/FI914906L/fi unknown
- 1991-10-17 NZ NZ240261A patent/NZ240261A/xx unknown
- 1991-10-17 KR KR1019910018300A patent/KR920008029A/ko not_active Withdrawn
- 1991-10-17 PL PL29208991A patent/PL292089A1/xx unknown
- 1991-10-17 CS CS913152A patent/CS315291A3/cs unknown
- 1991-10-17 AU AU85892/91A patent/AU638173B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US5212181A (en) | 1993-05-18 |
| MX9101604A (es) | 1992-06-05 |
| EP0481853A1 (fr) | 1992-04-22 |
| KR920008029A (ko) | 1992-05-27 |
| AU8589291A (en) | 1992-04-30 |
| NZ240261A (en) | 1993-01-27 |
| JPH04257579A (ja) | 1992-09-11 |
| FI914906A0 (fi) | 1991-10-17 |
| ZA918293B (en) | 1992-07-29 |
| CS315291A3 (en) | 1992-05-13 |
| HU913267D0 (en) | 1992-01-28 |
| CA2052760A1 (en) | 1992-04-19 |
| PL292089A1 (en) | 1992-06-26 |
| FR2668149B1 (fr) | 1994-09-23 |
| FI914906A7 (fi) | 1992-04-19 |
| IL99779A0 (en) | 1992-08-18 |
| FI914906L (fi) | 1992-04-19 |
| FR2668149A1 (fr) | 1992-04-24 |
| NO914071D0 (no) | 1991-10-17 |
| AU638173B2 (en) | 1993-06-17 |
| HUT59391A (en) | 1992-05-28 |
| IE913653A1 (en) | 1992-04-22 |
| PT99247A (pt) | 1992-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE781878L (en) | Imidazole derivatives | |
| NO153568C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater. | |
| FI870421A0 (fi) | Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi | |
| AU578947B2 (en) | Pyridazinones,preparation process thereof and utilization thereof, drugs containing pyridazinones | |
| DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
| DE68901153D1 (de) | Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung. | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| NO914071L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser | |
| AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| ES472847A1 (es) | Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion | |
| ATE18549T1 (de) | 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
| SE8305918L (sv) | Mellanprodukter for framstellning av bensimidazolderivat | |
| DK246180A (da) | Fremgangsmaade til fremstilling af paromomycinderivater | |
| DK379281A (da) | Azolylalkyl-derivater fremgangsmaade til deres fremstilling og deres anvendelse som fungicider | |
| ES8609482A1 (es) | Un metodo para producir acido dihidrodesoxigriseolico y sa- les y esteres del mismo | |
| EP0299076A4 (en) | 5-hydroxyindole-3-carboxamide compound and medicinal use thereof | |
| IE780279L (en) | Imidazole derivatives | |
| IE780926L (en) | Chromene derivatives | |
| YU119491A (sh) | Novi protivirusni tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja | |
| ES8504182A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
| ES482742A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas | |
| JPS5225740A (en) | Preparation of o-acyl-amidinophenols or acid addition salts thereof | |
| DK364386A (da) | 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| HUT51622A (en) | Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance |